June 12, 2019
Dr. Scott Howell, D.O., MPH & TM, CPE, Chief Medical Officer of RDx BioScience, a single source for care quality, risk evaluation and opioid expertise powered by a fast, full-service laboratory joins eHealth Radio and the Health News and Pharmaceutical Channels.
Listen to interview with host Eric Michaels & guest Dr. Scott Howell discuss the following:
- How are the new synthetic opioids, as we hear a lot about Fentanyl, different than an opiate like morphine?
- Is Fentanyl responsible for overdose deaths?
- What other risks are associated?
- How does this impact employers?
- What does RDx do to help tackle the addiction crisis?
Dr. Scott Howell is an acclaimed physician with over 25 years of clinical experience in medicine, public health and addiction. As the Chief Medical Officer for RDx BioScience, Scott leads our crusade to design and deliver meaningful value-based care. With expertise in the macro world of population health and day-to-day experience treating individual patients, he has deep insight into the capabilities of diagnostics in the diagnosis and treatment of chronic illness.
Scott brings extensive managed care experience with health plans, serving as National Senior Medical Director and Chief Medical Officer, Network and Population Health, Optum Insight, Regional Chief Medical Officer, Northeast Region of Americhoice, Inc., and National Medical Director of the Managed Care, AIDS Healthcare Foundation, with responsibility for international consulting in Russia, Ukraine, Guatemala, Honduras and Haiti. He most recently as Executive Medical Director at Heritage Provider Network.
He holds decades of hands-on practice experience, serving as Medical Director for the Broward Addiction and Recovery Center in Broward County, Florida, with oversight of a 40-bed detoxification center, 100-bed residential unit and over 5,000 outpatient visits per year in a public-funded setting. He continues to practice at Kaiser Permanente Los Angeles Medical Center’s Department of Addiction Medicine.
After serving in the U.S. military for 25 years, Dr. Howell is currently on military reserve assignment with the Office of Secretary of Defense at the Department of Defense Inspector General, concentrating on the Wounded Warrior Program, BioAssurity and Ebola Outbreak Assessment.
He earned a Master’s in Economics from the University of Miami, a Master’s in Public Health and Tropical Medicine from Tulane University, a Master’s in Business Administration (MBA) from California State University Fresno, and is certified by the American College of Physician Executives as a Certified Physician Executive (CPE).
Social Media Links: